Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MDR-1' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 103 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Li, J; Xu, LZ; He, KL; Guo, WJ; Zheng, YH; Xia, P; Chen, Y
      Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line

      BREAST CANCER RESEARCH
    2. Hayes, MC; Birch, BR; Cooper, AJ; Primrose, JN
      Cellular resistance to mitomycin C is associated with overexpression of MDR-1 in a urothelial cancer cell line (MGH-U1)

      BJU INTERNATIONAL
    3. Nicoletti, MI; Myers, TG; Fojo, T; Blagosklonny, MV
      Wild-type p53 marginally induces endogenous MDR-1 mRNA without causing a measurable drug resistance in human cancer cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    4. Matsumoto, Y; Takano, H; Kunishio, K; Nagao, S; Fojo, T
      Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    5. Perri, T; Fogel, M; Mor, S; Horev, G; Meller, I; Loven, D; Issakov, J; Kollender, Y; Smirnov, A; Zaizov, R; Cohen, IJ
      Effect of P-glycoprotein expression on outcome in the Ewing family of tumors

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    6. Liu, Q; Ohshima, K; Kikuchi, M
      High expression of MDR-1 gene and P-glycoprotein in initial and re-biopsy specimens of relapsed B-cell lymphoma

      HISTOPATHOLOGY
    7. Bredel, M
      Anticancer drug resistance in primary human brain tumors

      BRAIN RESEARCH REVIEWS
    8. Johnstone, RW; Tainton, KM; Ruefli, AA; Froelich, CJ; Cerruti, L; Jane, SM; Smyth, MJ
      P-glycoprotein does not protect cells against cytolysis induced by pore-forming proteins

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Ichihashi, N; Kitajima, Y
      Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells

      BRITISH JOURNAL OF DERMATOLOGY
    10. Ding, S; Chamberlain, M; McLaren, A; Goh, LB; Duncan, I; Wolf, CR
      Cross-talk between signalling pathways and the multidrug resistant proteinMDR-1

      BRITISH JOURNAL OF CANCER
    11. Sumimoto, Y; Maeda, Y; Naiki, Y; Sono, H; Miyatake, J; Sakaguchi, M; Matsuda, M; Kanamaru, A
      Establishment of a myeloid cell line, YM711, characterized by retinoid resistance

      LEUKEMIA & LYMPHOMA
    12. Johnstone, RW; Ruefli, AA; Tainton, KM; Smyth, MJ
      A role for P-glycoprotein in regulating cell death

      LEUKEMIA & LYMPHOMA
    13. Mazzella, FM; Kowal-Vern, A; Shrit, A; Rector, JT; Cotelingam, JD; Schumacher, HR
      Effects of multidrug resistance gene expression in acute erythroleukemia

      MODERN PATHOLOGY
    14. Ando, T; Nishimura, M; Oka, Y
      Decitabine (5-Aza-2 '-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells

      LEUKEMIA
    15. Sharma, N; Ramachandran, S; Bowers, M; Yegappan, M; Brown, R; Aziz, S; Chapman, R; Yu, BW
      Multiple factors other than p53 influence colon cancer sensitivity to paclitaxel

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    16. Fan, GC; Wu, CT
      Transfer of p14ARF gene in drug-resistant human breast cancer MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistance

      CANCER LETTERS
    17. Fairbairn, LJ; Rafferty, JA; Lashford, LS
      Engineering drug resistance in human cells

      BONE MARROW TRANSPLANTATION
    18. Duraj, J; Takacsova, X; Sedlak, J; Sulikova, M; Hunakova, L; Bies, J; Chorvath, B
      PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant

      ANTICANCER RESEARCH
    19. Lo Muzio, L; Staibano, S; Pannone, G; Mignogna, MD; Serpico, R; Rubini, C; Fioroni, M; Fanali, S; Piattelli, A
      The human multidrug resistance gene (MDR-1): Immunocytochemical detection of its expression in oral SCC

      ANTICANCER RESEARCH
    20. Larsen, AK; Escargueil, AE; Skladanowski, A
      Resistance mechanisms associated with altered intracellular distribution of anticancer agents

      PHARMACOLOGY & THERAPEUTICS
    21. Kamazawa, S; Kigawa, J; Minagawa, Y; Itamochi, H; Shimada, M; Takahashi, M; Sato, S; Akeshima, R; Terakawa, N
      Cellular efflux pump and interaction between cisplatin and paclitaxel in ovarian cancer cells

      ONCOLOGY
    22. Cocker, HA; Pinkerton, CR; Kelland, LR
      Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines

      BRITISH JOURNAL OF CANCER
    23. Tainton, KM; Ruefli, AA; Smyth, MJ; Johnstone, RW
      Equivalent death of P-glycoprotein expressing and nonexpressing cells induced by the protein kinase C inhibitor staurosporine

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    24. Omori, F; Juopperi, T; Chan, CK; Chang, YN; Phipps, S; Nanji, S; Zhao, YJ; Stewart, AK; Dube, ID
      Retroviral-mediated transfer and expression of the multidrug resistance protein 1 gene (MRP1) protect human hematopoietic cells from antineoplastic drugs

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    25. Mitrocotsa, D; Bosch, S; Mitaku, S; Dimas, C; Skaltsounis, AL; Harvala, C; Briand, G; Roussakis, C
      Cytotoxicity against human leukemic cell lines, and the activity on the expression of resistance genes of flavonoids from Platanus orientalis

      ANTICANCER RESEARCH
    26. Varga, A; Sokolowska-Kohler, W; Presber, W; Von Baehr, V; Von Baehr, R; Lucius, R; Volk, D; Nacsa, J; Hever, A
      Toxoplasma infection and cell free extract of the parasites are able to reverse multidrug resistance of mouse lymphoma and human gastric cancer cellsin vitro

      ANTICANCER RESEARCH
    27. Rimsza, LM; Rangel, CS; Grogran, TM
      Image analysis for quantitative evaluation of antigen retrieval efficacy demonstrates increased detection of P-glycoprotein in overfixed cells but decreased detection in optimally fixed cells

      JOURNAL OF HISTOTECHNOLOGY
    28. Grey, MR; Burgess, R; Fisher, A; Yin, JAL
      Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia

      LEUKEMIA RESEARCH
    29. Sharma, V; Piwnica-Worms, D
      Metal complexes for therapy and diagnosis of drug resistance

      CHEMICAL REVIEWS
    30. Rimet, O; Mirrione, A; Barra, Y
      Multidrug-resistant phenotype influences the differentiation of a human colon carcinoma cell line

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    31. Roepe, PD; Martiney, JA
      Are ion-exchange processes central to understanding drug-resistance phenomena?

      TRENDS IN PHARMACOLOGICAL SCIENCES
    32. OTSUKI T; SAKAGUCHI H; YAMADA O; YAWATA Y; UEKI A
      EFFECT OF THE NITROSOUREA ANTITUMOR CHEMOTHERAPEUTICAL AGENT MCNU ON 5 HUMAN MYELOMA CELL-LINES

      Oncology Reports
    33. HOSOI E; HIROSE M; HAMANO S; MORIMOTO M; KURODA Y
      EFFECT OF MDR ANTAGONISTS ON THE CIDAL ACTIVITY OF VINCRISTINE FOR CELLS EXPRESSING MDR-1 IS SUPERIOR TO THOSE EXPRESSING MRP

      International journal of oncology
    34. HABERL I; SWATONEK H; SCHAUFLER K; ULSPERGER E; WENZL E; THEYER G; HAMILTON G; THALHAMMER T
      P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE IS MODULATED BY PRETREATMENT WITH CHEMOSENSITIZERS IN HCT-8 CARCINOMA-CELLS IN-VITRO

      International journal of oncology
    35. DAMIANI D; MICHIELI M; ERMACORA A; CANDONI A; RASPADORI D; GEROMIN A; STOCCHI R; GRIMAZ S; MASOLINI P; MICHELUTTI A; SCHEPER R; BACCARANI M
      P-GLYCOPROTEIN (PGP), AND NOT LUNG RESISTANCE-RELATED PROTEIN (LRP), IS A NEGATIVE PROGNOSTIC FACTOR IN SECONDARY LEUKEMIAS

      Haematologica
    36. YOKOGAMI K; KAWANO H; MORIYAMA T; UEHARA H; SAMESHIMA T; OKU T; GOYA T; WAKISAKA S; NAGAMACHI S; JINNOUCHI S; TAMURA S
      APPLICATION OF SPET USING TC-99M SESTAMIBI IN BRAIN-TUMORS AND COMPARISON WITH EXPRESSION OF THE MDR-1 GENE - IS IT POSSIBLE TO PREDICT THERESPONSE TO CHEMOTHERAPY IN PATIENTS WITH GLIOMAS BY MEANS OF TC-99M-SESTAMIBI SPET

      European journal of nuclear medicine
    37. HIROSE M; KURODA Y
      P53 MAY MEDIATE THE MDR-1 EXPRESSION VIA THE WT1 GENE IN HUMAN VINCRISTINE-RESISTANT LEUKEMIA LYMPHOMA CELL-LINES/

      Cancer letters
    38. SEDLAK J; HUNAKOVA L; CHORVATH M; SULIKOVA M; NOVOTNY L; BOLJESIKOVA E; ZEILLINGER R; CHORVATH B
      RESISTANCE OF HUMAN MULTIDRUG-RESISTANT NEOPLASTIC CELL-LINES TO PACLITAXEL-INDUCED-RADIOSENSITIZATION IS REDUCED BY THE NONIMMUNOSUPPRESSIVE CYCLOSPORINE ANALOG SDZ PSC-833

      Anticancer research
    39. MOTOO Y; SU SB; NAKATANI MT; SAWABU N
      EXPRESSION OF MULTIDRUG-RESISTANCE GENE (MDR-1) MESSENGER-RNA IN GASTRIC AND COLORECTAL CANCERS

      Anticancer research
    40. YEH KH; CHEN CL; SHUN CT; LIN JT; LEE WJ; LEE PH; CHEN YC; CHENG AL
      RELATIVELY LOW EXPRESSION OF MULTIDRUG RESISTANCE-1 (MDR-1) AND ITS POSSIBLE CLINICAL IMPLICATION IN GASTRIC CANCERS

      Journal of clinical gastroenterology
    41. HUNAKOVA L; DURAJ J; ROMANOVA D; NOVOTNY L; SEDLAK J; KELLEY MR; SZEKERES T; JAYARAM HN; CHORVATH B
      STAUROSPORINE ENHANCED BENZAMIDE RIBOSIDE-INDUCED APOPTOSIS IN HUMAN MULTIDRUG-RESISTANT PROMYELOCYTIC LEUKEMIA-CELLS (HL-60 VCR) IN-VITRO/

      Neoplasma
    42. ROEPE PD
      THE P-GLYCOPROTEIN EFFLUX PUMP - HOW DOES IT TRANSPORT DRUGS

      The Journal of membrane biology
    43. YU DS; CHANG SY; MA CP
      THE EXPRESSION OF MDR-1-RELATED GP-170 AND ITS CORRELATION WITH ANTHRACYCLINE RESISTANCE IN RENAL-CELL CARCINOMA CELL-LINES AND MULTIDRUG-RESISTANT SUBLINES

      British Journal of Urology
    44. MICKLEY LA; LEE JS; WENG Z; ZHAN ZR; ALVAREZ M; WILSON W; BATES SE; FOJO T
      GENETIC-POLYMORPHISM IN MDR-1 - A TOOL FOR EXAMINING ALLELIC EXPRESSION IN NORMAL-CELLS, UNSELECTED AND DRUG-SELECTED CELL-LINES, AND HUMANTUMORS

      Blood
    45. SANDOR V; WILSON W; FOJO T; BATES SE
      THE ROLE OF MDR-1 IN REFRACTORY LYMPHOMA

      Leukemia & lymphoma
    46. ANDERSSON U; JOHANSSON S; LANDSTROM M; BJERMER L; HENRIKSSON R
      SMOKING ENHANCED THE EXPRESSION OF MDR-1 IN RAT PROSTATIC-CARCINOMA

      Oncology Reports
    47. YOON SS; FIDLER IJ; BELTRAN PJ; BUCANA CD; WANG YF; FAN D
      INTRATUMORAL HETEROGENEITY FOR AND EPIGENETIC MODULATION OF MDR-1 EXPRESSION IN MURINE MELANOMA

      Melanoma research
    48. STOCKING C; BAUM C
      GENE-TRANSFER INTO HEMATOPOIETIC-CELLS

      Bailliere's clinical haematology
    49. LI X; SMYTH AP; BARRETT DJ; IVY SP; VONHOFE E
      SENSITIZATION OF MULTIDRUG-RESISTANT HUMAN LEUKEMIA-CELLS WITH MDR1-TARGETED ANTISENSE AND INHIBITION OF DRUG-MEDIATED MDR1 INDUCTION

      Leukemia
    50. BROXTERMAN HJ; LANKELMA J; PINEDO HM; EEKMAN CA; WAHRER DCR; OSSENKOPPELE GJ; SCHUURHUIS GJ
      THEORETICAL AND PRACTICAL CONSIDERATIONS FOR THE MEASUREMENT OF P-GLYCOPROTEIN FUNCTION IN ACUTE MYELOID-LEUKEMIA

      Leukemia
    51. RAMACHANDRAN C; YOU W; KRISHAN A
      BCL-2 AND MDR-1 GENE-EXPRESSION DURING DOXORUBICIN-INDUCED APOPTOSIS IN MURINE LEUKEMIC P388 AND P388 R84 CELLS/

      Anticancer research
    52. MAYNADIE M; MATUTES E; CATOVSKY D
      QUANTIFICATION OF P-GLYCOPROTEIN IN CHRONIC LYMPHOCYTIC-LEUKEMIA BY FLOW-CYTOMETRY

      Leukemia research
    53. HUNAKOVA L; SEDLAK J; SULIKOVA M; CHOVANCOVA J; DURAJ J; CHORVATH B
      HUMAN MULTIDRUG-RESISTANT (MRP, P190) MYELOID-LEUKEMIA HL-60 ADR CELLS IN-VITRO - RESISTANCE TO THE MEVALONATE PATHWAY INHIBITOR LOVASTATIN/

      Neoplasma
    54. SEDLAK J; SULIKOVA M; CHORVATH M; HUNAKOVA L; NOVOTNY L; LAGINOVA V; SEVCIKOVA L; BOLJESIKOVA E; CHORVATH B
      TAXOL-ENHANCED CYTOTOXIC EFFECT OF RADIATION IN HUMAN PROMYELOCYTIC LEUKEMIA-CELLS - RELATIVE RESISTANCE OF MULTIDRUG-RESISTANT HL-60 CELLSIN-VITRO

      Neoplasma
    55. ROSIER RN; OKEEFE RJ; TEOT LA; FOX EJ; NESTER TA; PUZAS JE; REYNOLDS PR; HICKS DG
      P-GLYCOPROTEIN EXPRESSION IN CARTILAGINOUS TUMORS

      Journal of surgical oncology
    56. OBANA K; HASHIZUME K
      EXPRESSION OF MULTIDRUG RESISTANCE-RELATED P-GLYCOPROTEIN SHOWS GOOD PROGNOSIS IN NEUROBLASTOMA

      Journal of pediatric surgery
    57. MORAN E; LARKIN A; DOHERTY G; KELEHAN P; KENNEDY S; CLYNES M
      A NEW MDR-1 ENCODED P-170 SPECIFIC MONOCLONAL-ANTIBODY - (6 1C) ON PARAFFIN WAX EMBEDDED TISSUE WITHOUT PRETREATMENT OF SECTIONS/

      Journal of Clinical Pathology
    58. MICKLEY LA; SPENGLER BA; KNUTSEN TA; BIEDLER JL; FOJO T
      GENE REARRANGEMENT - A NOVEL MECHANISM FOR MDR-1 GENE ACTIVATION

      The Journal of clinical investigation
    59. MCKENNA SL; PADUA RA
      MULTIDRUG-RESISTANCE IN LEUKEMIA

      British Journal of Haematology
    60. ZHAN ZR; SANDOR VA; GAMELIN E; REGIS J; DICKSTEIN B; WILSON W; FOJO AT; BATES SE
      EXPRESSION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN GENE IN REFRACTORY LYMPHOMA - QUANTITATION BY A VALIDATED POLYMERASE CHAIN-REACTION ASSAY

      Blood
    61. UEDA K
      MDR 1 P-GLYCOPROTEIN - AN EFFLUX PUMP OF LIPOPHILIC XENOBIOTICS/

      Nippon Nogei Kagakukaishi
    62. OKADA Y
      MDR-1 AND VOLUME-SENSITIVE CHLORIDE CHANN EL

      Nippon Nogei Kagakukaishi
    63. FAN D; BELTRAN PJ; WANG YF; BUCANA CD; YOON SS; DEGUZMAN ACP; FIDLER IJ
      CELL DENSITY-DEPENDENT REGULATION OF MDR-1 GENE-EXPRESSION IN MURINE COLON-CANCER CELLS

      International journal of oncology
    64. WEIN D; GUPTA S
      EXPRESSION OF P-GLYCOPROTEIN, ENCODED BY MDR-1 GENE, A METABOLICALLY ACTIVE EFFLUX PUMP IN MURINE MAST-CELLS

      Cancer letters
    65. HE QY; ZHOU WD; JI L; ZHANG HQ; HE NG; XUE SB
      CHARACTERISTICS OF HARRINGTONINE-RESISTANT HUMAN LEUKEMIA HL-60 CELL

      Zhongguo yaoli xuebao
    66. JOLY P; LALLEMAND A; OUMHAMED Z; TRENTESAUX C; IDOINE O; DESPLACES A
      EFFECTS OF VERAPAMIL AND S9788 ON MDR-1 MESSENGER-RNA EXPRESSION STUDIED BY IN-SITU HYBRIDIZATION

      Anticancer research
    67. TSANGARIS GT; MOSCHOVI M; MIKRAKI V; VRACHNOU E; TZORTZATOUSTATHOPOULOU F
      STUDY OF APOPTOSIS IN PERIPHERAL-BLOOD OF PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA DURING INDUCTION THERAPY

      Anticancer research
    68. STEIN U; WALTHER W; SHOEMAKER RH
      VINCRISTINE INDUCTION OF MUTANT AND WILD-TYPE HUMAN MULTIDRUG-RESISTANCE PROMOTERS IS CELL-TYPE-SPECIFIC AND DOSE-DEPENDENT

      Journal of cancer research and clinical oncology
    69. RAFFERTY JA; HICKSON I; CHINNASAMY N; LASHFORD LS; MARGISON GP; DEXTER TM; FAIRBAIRN LJ
      CHEMOPROTECTION OF NORMAL-TISSUES BY TRANSFER OF DRUG-RESISTANCE GENES

      Cancer metastasis reviews
    70. HANTZOPOULOS PA; GANSBACHER B
      GENE-THERAPY - STATE-OF-THE-ART AND PERSP ECTIVES

      Chirurg
    71. KONDO S; KONDO Y; HARA H; KAAKAJI R; PETERSON JW; MORIMURA T; TAKEUCHI J; BARNETT GH
      MDM2 GENE MEDIATES THE EXPRESSION OF MDR1 GENE AND P-GLYCOPROTEIN IN A HUMAN GLIOBLASTOMA CELL-LINE

      British Journal of Cancer
    72. OTA S; SATO T; KAKUDA H; HIRANO K; OKIMOTO Y; MORI T; NAKAZAWA S; KOJIMA S; MATSUYAMA T; TSURUO T; FUSE A; NIIMI H
      EXPRESSION OF MDR-1 P-GLYCOPROTEIN IN CHILDHOOD ACUTE MEGAKARYOBLASTIC LEUKEMIA-CELLS/

      Leukemia & lymphoma
    73. SATO T; OTA S; KAKUDA H; MIURA N; NIIMI H; ITO M; ASAI T; TSURUO T; FUSE A
      EXPRESSION OF MULTIDRUG-RESISTANT GENE (MDR-1 P-GLYCOPROTEIN) IN A MEGAKARYOBLASTIC CELL-LINE, CMK, AND ITS ENHANCEMENT DURING MEGAKARYOCYTIC DIFFERENTIATION/

      Leukemia & lymphoma
    74. FINNEGAN MCM; ROYDS J; GOEPEL JR; LORIGAN P; HANCOCK BW; GOYNS MH
      MDR-1 EXPRESSION IN NON-HODGKINS-LYMPHOMAS IS UNRELATED TO TREATMENT INTENSITY OR RESPONSE TO THERAPY

      Leukemia & lymphoma
    75. SASAKI F; ISHIMURA H; HATA Y; UCHINO J
      RELATIONSHIP BETWEEN MDR-1 MESSENGER-RNA EXPRESSION AND ANTICANCER DRUG-SENSITIVITY IN HUMAN HEPATOCELLULAR-CARCINOMA CELL-LINES

      Oncology Reports
    76. HANANIA EG; FU S; RONINSON I; ZU Z; GOTTESMAN MM; DEISSEROTH AB
      RESISTANCE TO TAXOL CHEMOTHERAPY PRODUCED IN MOUSE MARROW-CELLS BY SAFETY-MODIFIED RETROVIRUSES CONTAINING A HUMAN MDR-1 TRANSCRIPTION UNIT

      Gene therapy
    77. HANANIA EG; FU S; ZU Z; HEGEWISCHBECKER S; KORBLING M; HESTER J; DURETT A; ANDREEFF M; MECHETNER E; HOLZMAYER T; RONINSON IB; GILES RE; BERENSON R; HEIMFELD S; DEISSEROTH AB
      CHEMOTHERAPY RESISTANCE TO TAXOL IN CLONOGENIC PROGENITOR CELLS FOLLOWING TRANSDUCTION OF CD34 SELECTED MARROW AND PERIPHERAL-BLOOD CELLS WITH A RETROVIRUS THAT CONTAINS THE MDR-1 CHEMOTHERAPY RESISTANCE GENE

      Gene therapy
    78. HELSON L; HELSON C; AINSWORTH S
      CAMPTOTHECIN CYTOTOXIC EFFECTS IN-VITRO - DEPENDENCY ON EXPOSURE DURATION AND DOSE

      Anti-cancer drugs
    79. DEAN M; ALLIKMETS R
      EVOLUTION OF ATP-BINDING CASSETTE TRANSPORTER GENES

      Current opinion in genetics & development
    80. KIM CJ; LEE YA; AHN HS; YUN CK; KIM CW; CHI JG
      AN IMMUNOHISTOCHEMICAL ANALYSIS OF MDR-1 AND BCL-2 EXPRESSIONS IN NEUROBLASTOMA

      Pathology research and practice
    81. PAIETTA E; ANDERSEN J; RACEVSKIS J; ASHIGBI M; CASSILETH P; WIERNIK PH
      MODULATION OF MULTIDRUG-RESISTANCE IN DE-NOVO ADULT ACUTE MYELOID-LEUKEMIA - VARIABLE EFFICACY OF REVERTING AGENTS IN-VITRO

      Blood reviews
    82. DEGREEF C; VANDERHEYDEN S; VIANA F; EGGERMONT J; DEBRUIJN EA; RAEYMAEKERS L; DROOGMANS G; NILIUS B
      LACK OF CORRELATION BETWEEN MDR-1 EXPRESSION AND VOLUME-ACTIVATION OFCHLORIDE-CURRENTS IN RAT COLON-CANCER CELLS

      Pflugers Archiv
    83. BHAT UG; WINTER MA; PEARCE HL; BECK WT
      A STRUCTURE-FUNCTION RELATIONSHIP AMONG RESERPINE AND YOHIMBINE ANALOGS IN THEIR ABILITY TO INCREASE EXPRESSION OF MDR1 AND P-GLYCOPROTEIN IN A HUMAN COLON-CARCINOMA CELL-LINE

      Molecular pharmacology
    84. MULLER C; GOUBIN F; FERRANDIS E; CORNILSCHARWTZ I; BAILLY JD; BORDIER C; BENARD J; SIKIC BI; LAURENT G
      EVIDENCE FOR TRANSCRIPTIONAL CONTROL OF HUMAN MDR1 GENE-EXPRESSION BYVERAPAMIL IN MULTIDRUG-RESISTANT LEUKEMIC-CELLS

      Molecular pharmacology
    85. VIANA F; VANACKER K; DEGREEF C; EGGERMONT J; RAEYMAEKERS L; DROOGMANS G; NILIUS B
      DRUG-TRANSPORT AND VOLUME-ACTIVATED CHLORIDE CHANNEL FUNCTIONS IN HUMAN ERYTHROLEUKEMIA-CELLS - RELATION TO EXPRESSION LEVEL OF P-GLYCOPROTEIN

      The Journal of membrane biology
    86. JONSSON K; DAHLBERG N; TIDEFELT U; PAUL C; ANDERSSON G
      CHARACTERIZATION OF AN ANTHRACYCLINE-RESISTANT HUMAN PROMYELOCYTE LEUKEMIA (HL-60) CELL-LINE WITH AN ELEVATED MDR-1 GENE-EXPRESSION

      Biochemical pharmacology
    87. RUSSO D; MARIE JP; ZHOU DC; FAUSSAT AM; DAMIANI D; MICHELUTTI A; MICHIELI M; FANIN R; BACCARANI M; ZITTOUN R; MELLI C
      EVALUATION OF THE CLINICAL RELEVANCE OF THE ANIONIC GLUTATHIONE-S-TRANSFERASE (GST-PI) AND MULTIDRUG-RESISTANCE (MDR-1) GENE COEXPRESSION IN LEUKEMIAS AND LYMPHOMAS

      Leukemia & lymphoma
    88. KATO S; IDEGUCHI H; FUTATA Y; HAMASAKI N; UMEMURA T; NISHIMURA J
      ANALYSIS OF MDR-1 GENE-EXPRESSION IN HUMAN LEUKEMIC-CELLS BY QUANTITATIVE COMPETITIVE PCR

      Leukemia & lymphoma
    89. GAZITT Y; CANTOR A; KOZA S; GRAHAMPOLE J
      A SAFE PROCEDURE FOR TRANSPORTING BONE-MARROW FOR PURGING IN A CENTRAL LABORATORY

      Oncology Reports
    90. BURGER H; NOOTER K; ZAMAN GJR; SONNEVELD P; VANWINGERDEN KE; OOSTRUM RG; STOTER G
      EXPRESSION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) IN ACUTE AND CHRONIC LEUKEMIAS

      Leukemia
    91. CHEVILLARD S; VIELH P; POUILLART P
      MDR1 GENE-TRANSCRIPTION IN BREAST-CANCER CELLS

      Pathologie et biologie
    92. KIEHNTOPF M; BRACH MA; LICHT T; PETSCHAUER S; KARAWAJEW L; KIRSCHNING C; HERRMANN F
      RIBOZYME-MEDIATED CLEAVAGE OF THE MDR-1 TRANSCRIPT RESTORES CHEMOSENSITIVITY IN PREVIOUSLY RESISTANT CANCER-CELLS

      EMBO journal
    93. WALTHER W; STEIN U
      INFLUENCE OF CYTOKINES ON MDR1 EXPRESSION IN HUMAN COLON-CARCINOMA CELL-LINES - INCREASED CYTOXICITY OF MDR RELEVANT DRUGS

      Journal of cancer research and clinical oncology
    94. LEE JS; PAULL K; ALVAREZ M; HOSE C; MONKS A; GREVER M; FOJO AT; BATES SE
      RHODAMINE EFFLUX PATTERNS PREDICT P-GLYCOPROTEIN SUBSTRATES IN THE NATIONAL-CANCER-INSTITUTE DRUG SCREEN

      Molecular pharmacology
    95. ISOBE H; WELLHAM L; SAUERTEIG A; SRIDHAR KS; RAMACHANDRAN C; KRISHAN A
      DOXORUBICIN RETENTION AND CHEMORESISTANCE IN HUMAN MESOTHELIOMA CELL-LINES

      International journal of cancer
    96. ARAO S; SUWA H; MANDAI M; TASHIRO H; MIYAZAKI K; OKAMURA E; NOMURA H; HIAI H; FUKUMOTO M
      EXPRESSION OF MULTIDRUG-RESISTANCE GENE AND LOCALIZATION OF P-GLYCOPROTEIN IN HUMAN PRIMARY OVARIAN-CANCER

      Cancer research
    97. BURGER H; NOOTER K; SONNEVELD P; VANWINGERDEN KE; ZAMAN GJR; STOTER G
      HIGH EXPRESSION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) IN CHRONIC AND PROLYMPHOCYTIC LEUKEMIA

      British Journal of Haematology
    98. WOOD P; BURGESS R; MACGREGOR A; YIN AL
      P-GLYCOPROTEIN EXPRESSION ON ACUTE MYELOID-LEUKEMIA BLAST CELLS AT DIAGNOSIS PREDICTS RESPONSE TO CHEMOTHERAPY AND SURVIVAL

      British Journal of Haematology
    99. WALL DM; SPARROW R; HU XF; NADALIN G; ZALCBERG JR; MARSCHNER IC; VANDERWEYDEN M; PARKIN JD
      CLINICAL-APPLICATION OF A RAPID, FUNCTIONAL ASSAY FOR MULTIDRUG RESISTANCE BASED ON ACCUMULATION OF THE FLUORESCENT DYE, FLUO-3

      European journal of cancer
    100. CLYNES M; HEENAN M; HALL K
      HUMAN CELL-LINES AS MODELS FOR MULTIDRUG-RESISTANCE IN SOLID TUMORS

      Cytotechnology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 20:39:16